• ABPI Website
  • Media
  • Temporary changes to publication of 2019 data on Disclosure UK in June 2020

Temporary changes to publication of 2019 data on Disclosure UK in June 2020

The ABPI is making a temporary change to the way Disclosure UK data is published to minimise any pressure on the NHS during the COVID-19 pandemic. 

Disclosure UK is the public, searchable database that shows payments and benefits in kind made by the pharmaceutical industry to healthcare professionals and organisations in the UK.

In June 2020, the ABPI will be disclosing 2019 data in a way which minimises any pressure on NHS workers, hospitals and other NHS organisations as they respond to the COVID-19 pandemic.

This means that some of the data will not be broken down as normal. This is a temporary change because of the unprecedented situation, and we remain committed to resuming the normal process as soon as the situation allows.

A full technical statement on the change is available here. 

For media questions on this, contact the ABPI press office at PressOffice@abpi.org.uk or 020 7747 7147. 

For all other questions, contact info@disclosure.org.uk.  

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.